Summary
The elderly respond differently to drugs than do younger people. Their physiological response is much more variable, and predictability of drug action is much less certain. When all non-pharmacological factors and age-associated pharmacokinetics are taken into account, there is still no full explanation of the potentially altered drug action and increased drug toxicity observed in the elderly. It is only relatively recently that age-associated physiological changes (primary age changes), their interplay with age-associated pathophysiological changes (secondary age changes) and environmental changes (tertiary age changes) have been studied with regard to the effect of those changes on the pharmacodynamics of drug action. In general, age-associated pharmacodynamic changes, i.e. changes in the type, intensity and duration of drug action, have been associated with changes in receptor function (e.g. altered receptor number and affinity, altered second messenger function, altered cell response), changes in the homeostatic mechanisms, and reduced reserve capacity.
It is important to realise that these changes, which can differ greatly among patients, may be responsible for an increased incidence of adverse drug reactions and therapeutic failure. They may also mandate a higher dose in some circumstances, as some organs become less responsive to drug action with age.
Similar content being viewed by others
References
Abbrass IB, Scarpace PJ. Human lymphocyte beta-adrenergic receptors are unaltered with age. Journal of Gerontology 36(3) 298–301, 1981
Adelman RC. Loss of adaptive mechanism during aging. Federation Proceedings 38(6): 1968–1971, 1979
Anderson JM, Hubbard BM, Coghill GR, Sidders W. The effect of advanced old age on the neuron content of the cerebral cortex: observations with an automatic image analyzer point counting method. Journal of Neurological Science 58(2): 235–246, 1983
Andres R, Tobin JD. Endocrine system. In Finch GE & Hayflick L (Eds) Handbook of the biology of aging, pp. 357–378, Van Norstrand Reinhold, New York, 1977
Avorn J, Everitt D, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. Journal of the American Medical Association 255: 357–360, 1986
Bachmann K, Shapiro R, Machiewicz J. Warfarin elimination and responsiveness in patients with renal dysfunction. Journal of Clinical Pharmacology 17: 292–299, 1977
Bar RS, Roth J. Insulin receptor status in disease states of man. Archives of Internal Medicine 137(4): 474–481, 1977
Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 68: 560–566, 1975
Beckham J, Hertrampf R, Gundert-Remy U, Mikus G, Gross AS, et al. Is there a genetic factor in flecainide toxicity? British Medical Journal 297: 1316, 1988
Bell MJ. Neuronal loss, neurofibrillary tangles, and granulovascular degeneration in the hippocampus with aging and dementia: a quantitative study. Acta Neuropathologica (Berlin) 37: 111–118, 1977
Bellville JW. Influence of age on pain relief from analgesics: a study of postoperative patients. Journal of the American Medical Association 217: 1835–1841, 1971
Bend F. Clinical aspects of the aging heart. Zeitschrift fur Kardiologie 74(Suppl. 1): 49–54, 1985
Bender AD. Pharmacologic aspects of aging: a survey of the effect of increasing age on drug activity in adults. Journal of the American Geriatrics Society 12: 114–134, 1964
Bertel O, Buehler FR, Kiowski W, Lutold BE. Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with esssential hypertension. Hypertension 2(2): 130–138, 1980
Bleich HL, Boro ES, Rowe JW. Clinical research on aging: strategies and directions. New England Journal of Medicine 297(24): 1332–1336, 1977
Bowen DM, Davidson AN. The failing brain. Journal of Chronic Diseases 36(1): 3–13, 1983
Brodde OE, Anlauf M, Graben N, Bock KD. Age dependent decrease of alpha-2 adrenergic receptor number in human platelets. European Journal of Pharmacology 81: 345–347, 1982
Buehler FR. Age and cardiovascular response adaptation. Hypertension 5(Suppl. 111): 94–100, 1983
Buehler FR, Burkart F, Lutold B, Kung M, Marbet G, et al. Antihypertensive beta blocking action is related to renin and age: a pharmacologic tool to identify pathogenic mechanisms in essential hypertension. American Journal of Cardiology 36(5): 653–669, 1975
Buehler FR, Hulthen UL, Kiowski W, Bolli P. Beta blockers and calcium antagonists: cornerstones of antihypertensive therapy in the 1980s. Drugs 25(Suppl. 2): 50–57, 1983
Bursztyn M, Breshnahan M, Gavras H. Effect of aging on vasopressin, catecholamines, and alpha-2-adrenergic receptors. Journal of the American Geriatrics Society 38: 628–632, 1990
Caird FI, Andrews GR, Kennedy RD. Effect of posture on blood pressure in the elderly. British Heart Journal 35(5): 527–530, 1973
Ceuppens JL, Goodwin JS. Regulation of immunoglobulin production in pokeweed mitogen-stimulated cultures of lymphocytes from young and old adults. Journal of Immunology 128(6): 2429–2434, 1982
Cobliegh MA, Braun DP, Harris JE. Age-dependent changes in human peripheral blood B-cells and T-cells subsets: correlation with mitogen responsiveness. Clinical Journal of Immunology and Immunopathology 15(2): 162–174, 1980
Collins KJ, Dore C, Exton-Smith AN, Fox RH, MacDonald IC, et al. Accidental hypothermia and impaired temperature homeostasis in the elderly. British Medical Journal 1: 353–356, 1977
Conway J, Wheeler R, Saumerstedt R. Sympathetic nervous system activity during exercise in relation to age. Cardiovascular Research 5: 577–581, 1971
Cooper C, Barker DJP, Morris J, Briggs RS. Osteoporosis, falls, and age in fracture of the proximal femur. British Medical Journal 295: 13–15, 1987
Crane MG, Harris JJ. Effect of age on renin activity and aldosterone excretion. Journal of Laboratory and Clinical Medicine 87: 947–959, 1976
Crooks J. Aging and drug disposition: pharmacodynamics. Journal of Chronic Diseases 36(1): 85–90, 1983
Culver BH, Butler J. Alterations in pulmonary functions. In Andres R et al. (Eds) Principles of geriatric medicine, pp. 280–287, McGraw-Hill Book Co., New York, 1985
Cusack BJ, Vestal RE. Clinical pharmacology: special considerations in the elderly. In Calkins E, et al. (Eds) The practice of geriatrics, pp. 115–134, WB Saunders Co., Philadelphia PA, 1986
Cutler NR, Zavadil III AP, Eisdorfer C, Ross RJ, Potter WZ. Concentrations of desipramine in elderly women. American Journal of Psychiatry 138(9): 1235–1237, 1981
Davidson MB. The effect of aging on carbohydrate metabolism: a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 28(6): 688–705, 1979
Docherty JR. Aging and the cardiovascular system. Journal of Autonomic Pharmacology 6(1): 77–84, 1986
Duara R, Grady C, Haxby J. Human brain utilization and cognitive function in relation to age. Annals of Neurology 16: 702–713, 1984
Duara R, Margolin RA, Robertson-Tchabo EA, London ED, Schwartz M. Cerebral glucose utilization, as measured with positron emission tomography, in 21 resting healthy men between the ages of 21 and 83 years. Brain 106: 761–775, 1983
Dubner R. Peripheral and central mechanisms of pain. Age 10: 31–34, 1987
Dyckner T, Wester PO. Intracellular magnesium loss after diuretic administration. Drugs 28(Suppl. 1): 161–166, 1984
Epstein M, Hollenberg NK. Age as a determinant of renal sodium conservation in normal man. Journal of Laboratory and Clinical Medicine 87(3): 411–417, 1976
Esler M. Age-dependence of noradrenaline kinetics in normal subjects. Clinical Science 60(2): 217–219, 1981
Evans JG, Jarvis EH. Nitrazepam and the elderly. British Medical Journal 4(838): 487, 1972
Evans MH, Triggs EJ, Cheon M. Gastric emptying rate in the elderly: implications for drug therapy. Journal of the American Geriatrics Society 29: 201–205, 1981
Everitt DE, Avorn J. Drug prescribing for the elderly. Archives of Internal Medicine 146(12): 2393–2396, 1986
Feely J, Stevenson IH. The influence of ageing on propranolol concentration binding and efficacy in hyperthyroid patients. Journal of Clinical and Experimental Gerontology 1: 173–184, 1979
Feldman RD, Limbird LE, Nadeau J, Fitzgerald GA, Robertson D, et al. Dynamic regulation of leukocyte beta-adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines. Journal of Clinical Investigation 72(1): 164–170, 1983
Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ. Alterations in leukocyte beta-receptor affinity with aging: a potential explanation for altered beta-adrenergic sensitivity in the elderly. New England Journal of Medicine 310: 815–819, 1984
Fink RI, Kilternan DG, Griffin J, Olafinski K. Mechanisms of insulin resistance in ageing. Journal of Clinical Investigation 50: 1523–1535, 1983
Fleisch JH. Age-related changes in the sensitivity of blood vessels to drugs. Pharmacology and Therapeutics 8(2): 477–487, 1980
Fox RH, MacGibbon R, Davies L, Woodward PM. Problems of the old and the cold. British Medical Journal 1: 21–24, 1973
Gachalyi B, Vas A, Hajos P, Kaldor A. Acetylator phenotypes: effect of age. European Journal of Clinical Pharmacology 26(1): 43–45, 1984
Gardner ID. The effect of aging on susceptibility to infection. Review of Infectious Diseases 2(5): 801–810, 1980
Geokas MD, Haverback BJ. The aging gastrointestinal system. American Journal of Surgery 117: 881–892, 1969
Gerbino PP, Gans JA. Antacids and laxatives for symptomatic relief in the elderly. Journal of the American Geriatrics Society 30(Suppl. 11): S81–S87, 1982
Greenberg LJ, Yunis EJ. Histocompatibility determinants, immune responsiveness, and aging in man. Federation Proceedings 37(5): 1258–1262, 1978
Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circulation Research 29(4): 424–431, 1971
Grossman MI, Kirsner JB, Gillespie IE. Basal and histolog-stimulated gastric secretion in control subjects and patients with peptic ulcer or gastric ulcer. Gastroenterology 45: 14–26, 1983
Guarnieri T, Filburn CR, Zitnik G, Roth GS, Lakatta EG. Contractile biochemical correlates of beta-adrenergic stimulation of the aged heart. American Journal of Physiology 239(4): H501–H508, 1980
Hale WE, Perkins LL, May FE, Marks RG, Stewart RB. Symptom prevalence in the elderly. Journal of the American Geriatrics Society 34: 333–340, 1986
Harper CM, Newton PA, Walsh JR. Drug-induced illness in the elderly. Postgraduate Medicine 86(2): 245–256, 1989
Hickler RB. Aging and hypertension: hemodynamic implications of systolic pressure trends. Journal of the American Geriatrics Society 31(7): 421–425, 1983
Hickler RB. The physiology of aging: implications for drug therapy. In Hoffer EP (Ed.) Emergency problems in the elderly, pp. 1–17, NJ Medical Economic Books, Oradell, NJ, 1985
Hilzenberger G, Fitscha P, Beveridge T, Nuesch E, Pacha W. Influence of smoking on pharmacokinetics of beta-receptor blockers. Gerontology 28(Suppl. 1): 93–100, 1982
Hollis JB, Castell DO. Esophageal function in elderly men: a new look at ‘presbyesophagus’. Annals of Internal Medicine 80: 371–374, 1974
Holt PR. Age-related changes in the gut. Geriatric Medicine Today 4: 44–53, 1985
Hurwitz AL, Nelson JA, Haddad JK. Oropharyngeal dysphagia: manometric and cine-esophagraphic findings. American Journal of Digestive Diseases 23: 275–281, 1975
Jackson G, Pierscianowski TA, Mahon W, Condon J. Inappropriate antihypertension therapy in the elderly. Lancet 2: 1317–1318, 1976
Johnson PC. Gastrointestinal consequences of treatment with drugs in elderly patients. Journal of the American Geriatrics Society 30(Suppl. 1): S52–S57, 1984
Jones BR, Baran A, Reidenberg MM. Evaluating patients’ warfarin requirements. Journal of the American Geriatrics Society 28(1): 10–12, 1980
Kaplan AP. Drug-induced skin disease. Journal of Allergy and Clinical Immunology 74(4): 573–579, 1984
Kellett HA, Sawers JSA, Boulton FE, Cholerton S, Park BK, et al. Problems of anticoagulation with warfarin in hyper-thyroidism. Quarterly Journal of Medicine 58: 43–51, 1986
Kelliher GJ, Conahan ST. Changes in vagal activity and response to muscarinic receptor agonists with age. Journal of Gerontology 45: 842–849, 1980
Kenney RA. Physiology of aging: In Geokas MC (Ed.) The aging process. Clinics in Geriatric Medicine 1(1): 37–59, 1985
Kirchheim HR. Systematic arterial baroreceptor reflexes. Physiology Review 56(1): 100–177, 1976
Klausner SC, Schwartz AB. The aging heart. Clinics in Geriatric Medicine 1(1): 119–141, 1985
Klein C, Gerber JG, Gal J, Nies AS. Beta-adrenergic receptors in the elderly are not less sensitive to timolol. Clinical Pharmacology and Therapeutics 40(2): 161–164, 1986
Kohn RR. Human aging and disease. Journal of Chronic Diseases 16: 5–9, 1983
Krall JF, Connelly M, Weisbart R, Tuck ML. Age-related elevation of plasma catecholamine concentrations and reduced responsiveness of lymphocyte adenylate cyclase. Journal of Clinical Endocrinology and Metabolism 52(5): 863–867, 1981
Krentz K, Jablonowski H. Functional and histological gastric changes with age. In Hellemans J & Vantrappen G (Eds) Gastrointestinal tract disorders in the elderly, pp. 62–69, Churchill Livingstone, New York, 1984
Lakatta EG. Determinants of cardiovascular performance: modification due to aging. Journal of Chronic Diseases 36(1) 15–30, 1983
Lakatta EG, Gerstenblith G, Angell CS, Shock NW, Weisfeld ML. Diminished inotropic response of the aged myocardium to catecholamines. Circulation Research 36(2): 262–269, 1975
Lake CR, Ziegler MG, Coleman MD, Kopin IJ. Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. New England Journal of Medicine 296(4): 208–209, 1977
Lamy ML. Drugs in oral health. Journal of the Maryland Dental Association 27(3): 125–130, 1984
Lamy PP. Prescribing for the elderly, pp. 249–292, PSG Publishing Co., Littleton, MA, 1980
Lamy PP. Over-the-counter medications: the drug interactions we overlook. Journal of the American Geriatrics Society 30(Suppl. 11): S69–S75, 1982
Lamy PP. Drug-nutrient interactions in the aged. In Watson RR (Ed.) CRC Handbook of nutrition in the aged, pp. 248–278, CRC Press Inc., Boca Raton, Florida, 1985
Lamy PP. Drug therapy in the elderly. Pharmacy International 7: 46–59, 1986a
Lamy PP. Nonsteroidal anti-inflammatories in the elderly. In Rainsford KD & Velo GP (Eds) Side effects of anti-inflammatory drugs, MTP Press Ltd, Lancaster, England, 1986b
Lamy PP. Adverse drug reactions and the elderly: an update. In Ham RJ (Ed. P Geriatric medicine annual 1986, pp. 128–154, Medical Economics Books, Oradell, NJ, 1986c
Lamy PP. Age-associated pharmacodynamic changes. Methods and Findings in Experimental and Clinical Pharmacology 9(3): 13–17, 1987
Lamy PP. A consideration of NSAID use in the elderly. Geriatric Medicine Today 7(4): 1–11, 1988
Lamy PP. Age-related pharmacodynamic changes. ElderCare News 5(4) 25–33, 1989
Lamy PP, Lesko LJ. Altered drug action in the elderly. In Bailey DM (Ed.) Annual reports in medicinal chemistry 20: 295–313, 1985
Lamy PP, Overholser Jr CD, Lamy ML. Therapeutic implications. In Tryon AF (Ed.) Oral health and aging, pp. 105–138, PSG Publishing Co., Littleton, MA, 1986a
Lamy PP. Overholser Jr CD, Lamy ML. Nutritional deficiencies. In Tryon AF (Ed.) Oral health and aging, pp. 159–205, PSG Publishing Co., Littleton, MA, 1986b
Larson EB, Kukuli WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Annals of Internal Medicine 107(1): 169–173, 1987
Laventurier MF, Talley RB, Hefner DL, Kennard LH. Drug utilization and potential drug-drug interactions. Journal of the American Pharmaceutical Association 16(2): 77–81, 1976
Leaf A. Dehydration in the elderly. New England Journal of Medicine 311: 791–792, 1984
Lefkowitz RJ, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation: biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. New England Journal of Medicine 310(24): 1570–1579, 1984
Livingston RL, Zucker DK, Isenberg K, Wetzel RD. Tricyclic antidepressants and delirium. Journal of Clinical Psychiatry 44(5): 173–176, 1983
London GM, Safer MD, Weiss YA, Milliez PL. Isoproterenol sensitivity and total body clearance of propranolol in hypertensive patients. Journal of Clinical Pharmacology 16(4): 174–183, 1976
Lund-Johansen P. The hemodynamics of the aging cardiovascular system. Journal of Cardiovascular Pharmacology 12(Suppl. 8): S20–S32, 1988
Makinodan T, Kay MMB. Age influence on the immune system. Advances in Immunology 29: 287–330, 1980
Martin CJ, Das S, Young AC. Measurement of the dead space volume. Journal of Applied Physiology 47: 319–324, 1979
McAllister RG. Age-related changes in drug handling in man. American Journal of Cardiology 57: 59C–62C, 1986
McGeer EG. Aging and neurotransmitter metabolism in human brain. In Katzman R et al. (Eds) Alzheimer’s disease: senile dementia and related disorders, pp. 427–440, Raven Press, New York, 1978
McGeer PL, McGeer EG, Suzuki PS. Aging and extrapyramidal function. Archives of Neurology 34: 33–35, 1977
Memo M, Spano PF, Trabucchi M. Brain benzodiazepine receptor changes during aging. Journal of Pharmacy and Pharmacology 33(1): 64, 1981
Messerli FH. Individualization of antihypertensive therapy: an approach based on hemodynamics and age. Journal of Clinical Pharmacology 21: 517–528, 1981
Messerli FH, Dreslinski GR, Husserl FE, Suarex DH, MacPhee AA, et al. Antiadrenergic therapy: special aspects in hypertension in the elderly. Hypertension 3(Suppl. 2): 226–229, 1981
Messerli FH, Losem CJ. Antihypertensive therapy in the elderly. In Lamy PP (Ed.) Clinical pharmacology. Clinics in Geriatric Medicine 6(2): 335–344, 1990
Meyer BR. Benzodiazepines in the elderly. Medical Clinics of North America 66(5): 1017–1035, 1982
Mikiten T. Central nervous system integrative functions. In Masoro EJ (Ed.) Handbook of physiology of aging, pp. 3–5, CRC Press, Boca Raton, 1981
Norris AD, Shock NW, Yiengst MJ. Age changes in heart rate and blood pressure responses to tilting and standardized exercise. Circulation 8: 521–526, 1953
O’Brien WM. Pharmacology of nonsteroidal anti-inflammatory drugs. American Journal of Medicine 76: 32–39, 1983
O’Malley K, Kelly JC, Swift CG. Responsiveness to drugs. In Swift CG (Ed.) Clinical pharmacology in the elderly, pp. 83–101, Marcel Dekker Inc., New York, 1987
O’Malley K, Stevenson IH, Ward CA, Wood AJJ, Crooks J. Determination of anticoagulant control in patients receiving warfarin. British Journal of Clinical Pharmacology 4: 309–314, 1977
Orlander P, Johnson DG. Endocrinologic problems in the aged. Otolaryngology Clinics of North America 15(2): 439–449, 1982
Phillips PA, Rolls BJ, Ledingham JG, Forsling ML, Morton JJ, et al. Reduced thirst after water deprivation in healthy elderly men. New England Journal of Medicine 311(12): 753–759, 1984
Portenoy RK. Optimal pain control in elderly cancer patients. Geriatrics 42(5): 33–44, 1987
Powell S, Schwartz P, Rayment C, Marx CM. Pharmacy-based adverse drug reaction surveillance program. American Journal of Hospital Pharmacy 39(11): 1963–1964, 1982
Price GB, Makindon T. Immunological deficiencies in senescence. I. Characterization of intrinsic deficiencies. Journal of Clinical Immunology 108: 302, 1972
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton J. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316(7): 363–369, 1987
Ray WA, Griffin MR, Shorr RI. Adverse drug reactions and the elderly. Health Affairs 9: 114–122, 1990
Reid JL. Neurogenic factors in hypertension. Triangle 23: 7–10, 1984
Rizzato G, Marazzini L. Thoroabdominal mechanics in the elderly. Journal of Applied Physiology 28: 457–460, 1970
Robbins AS, Rubenstein LZ. Postural hypotension in the elderly. Journal of the American Geriatrics Society 32: 769–774, 1984
Roberts J, Turner N. Pharmacodynamic basis for altered drug action in the elderly. Clinics of Geriatric Medicine 4(1): 127–150, 1988
Robinson MG, Griffin JW, Bowers J, et al. Effect of ranitidine gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Digestive Diseases and Sciences 34(3): 424–428, 1989
Rossor MN, Iverson LL, Johnson AJ. Mountjob CQ, Roth M. Cholinergic deficit in frontal cerebral cortex in Alzheimer’s disease is age dependent. Lancet 2: 1422, 1981
Routledge PA, Chapman PH, Davies DM, Rawlins MD. Pharmacokinetics and pharmacodynamics of warfarin at steady state. British Journal of Clinical Pharmacology 8: 243–247, 1979
Rowe JW, Shock NW, DeFronzo RA. The influence of age on the renal response to water deprivation in man. Nephron 17: 270, 1976
Rowe JW, Troen BR. Sympathetic nervous system and aging in man. Endocrinology Review 1(2): 167–179, 1980
Rowley MJ, Buchanan H, MacKay IT. Reciprocal change with age in antibody to extrinsic and intrinsic antigens. Lancet 2: 24–26, 1968
Roy R, Thomas M. A survey of chronic pain in an elderly population. Canadian Family Physician 32: 513–516, 1986
Sartin J, Chaudhuri M, Obenrader M, Adelman RC. The role of hormones in changing adaptive mechanisms during aging. Federation Proceedings 39(14): 3163–3167, 1980
Scarpace PJ, Turner N, Mader SL. β-Adrenergic function in aging: basic mechanisms and clinical implications. Drugs & Aging 1(2): 116–129, 1991
Schmucker DL. Aging and drug disposition: an update. Pharmacology Review 37(2): 133–148, 1985
Schmucker DL, Daniels CK. Aging, gastrointestinal infections, and mucosal immunity. Journal of the American Geriatrics Society 34(5): 377–384, 1986
Schocken DD, Roth GS. Reduced beta-adrenergic receptor concentration in ageing man. Nature 267: 856, 1977
Schumacher GE. Using pharmacokinetics in drug therapy. VII. Pharmacokinetic factors influencing drug therapy in the aged. American Journal of Hospital Pharmacy 37(4): 559–562, 1980
Schwartz JB, Abernethy DR. Cardiac drugs: adjusting their use in aging patients. Geriatrics 42(8): 31–34, 37-40, 1987
Scordamaglia A, Ciprandi G, Indiveri F, Canonica GW. The effect of aging on host defences: implications for therapy. Drugs & Aging 1: 303–316, 1991
Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. Journal of Pharmacology and Experimental Therapy 240(1): 159–166, 1987
Scott PJ, Reid JL. The effect of age on the response of human isolated arteries to noradrenaline. British Journal of Clinical Pharmacology 13(2): 237–239, 1982
Severson JA. Neurotransmitter receptors and aging. Journal of the American Geriatrics Society 32(1): 24–27, 1984
Shepherd AMM, Elfellah MS. Effect of age on muscarinic responses in the rat heart. Clinical Research 32: 862A, 1984
Shock NW. Aging of the physiological systems. Journal of Chronic Diseases 36: 137–142, 1983
Simons KJ, Watson WTA, Chen XY, Simons FER. Pharmacokinetics and pharmacodynamic studies of the H2 receptor antagonist hydroxyzine in the elderly. Clinical Pharmacology and Therapeutics 45: 9–14, 1989
Sklar M. Gastrointestinal diseases in the elderly. In Reichel W (Ed.) Clinical aspects of aging, pp. 205–217, Williams & Wilkins, Baltimore, MD, 1983
Smith IM. Infections in the elderly. Hospital Practice 17(7): 69–77, 81-85, 1982
Snyder SH. Receptors, neurotransmitters and drug responses. New England Journal of Medicine 300(9): 465–472, 1979
Swales JD. Pathophysiology of blood pressure in the elderly. Age and Ageing 8(2): 104–109, 1979
Swift CG. Prescribing in old age. British Medical Journal 296: 913–915, 1988
Swift CG, Swift MR, Ankier SI, Pidgen A, Robinson J. Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. British Journal of Clinical Pharmacology 20(2): 119–128, 1985
Thompson 2nd TL, Moran MG, Nies AS. Psychotropic drug use in the elderly. New England Journal of Medicine 308(4): 194–199, 1983
Thurlbeck WM, Angus GE. Growth and aging of the normal human lung. Chest 67: 38–78, 1975
Tomlinson BE, Henderson G. Some quantitative cerebral findings in normal and demented old people. In Terry RD & Gershon S (Eds) Neurobiology of aging, Raven Press, New York, 1976
Tsujimoto G, Hashimoto K, Hoffman BB. Pharmacokinetic and pharmacodynamic principles of drug therapy in old age. International Journal of Clinical Pharmacology Therapy and Toxicology 27(1): 13–26, 1989
Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamil in asthma. Thorax 36(7): 523–529, 1981
Veith RC, Raskind MA, Branes RF. Tricyclic antidepressants and supine, standing and exercise plasma norepinephrine levels. Clinical Pharmacology and Therapeutics 33: 763, 1983
Vernadakis A. The aging brain. Clinics in Geriatric Medicine 1(1): 61–94, 1985
Vestal RE. Drugs use in the elderly: a review of problems and special considerations. Drugs 16(4): 352–382, 1978
Vestal RE, Wood AJJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clinical Pharmacology and Therapeutics 26(2): 181–186, 1979
Wagner HN, Burns HD, Dannals RF, Wong DF, Langstrom B, et al. Imaging dopamine receptors in the human brain by positron tomography. Science 221: 1264–1266, 1983
Waldorf DS, Wilkens RF, Decker JL. Impaired delayed hypersensitivity in an aging population. Journal of the American Medical Association 203(10): 831–834, 1968
Wall RT. Use of analgesics in the elderly. In Lamy PP (Ed.) Clinical pharmacology. Clinics in Geriatric Medicine 6(2): 345–364, 1990
Watson AJM, Pegg M, Green JRB. Enteral feeds may antagonise warfarin. British Medical Journal 288: 557, 1984
Weksler ME, Hutteroth TM. Impaired lymphocyte function in aged humans. Journal of Clinical Investigation 53(1): 99–104, 1974
Whitehouse PJ, Parhad IM, Hedeen JC, Clark AW, White III CL, et al. Integrity of nucleus basalis of Meynert in normal aging. Neurology 33(Suppl. 2): 159, 1983
Zeigler MG, Lake CR, Kopin IN. Plasma noradrenaline increases with age. Nature 261: 333–335, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lamy, P.P. Physiological Changes Due to Age. Drugs & Aging 1, 385–404 (1991). https://doi.org/10.2165/00002512-199101050-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101050-00006